Michael A. Mussallem, Chairman & CEO at Edwards Lifesciences Corp (EW), sold 46,850 shares at $83.38 ($3.1M) on 2022-10-14, disclosed to the SEC on 2022-10-14.
Seasonal sale ($3.1M) by Chairman & CEO — this insider has traded EW in October in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 9,500 | $0 | 0.0% |
| 2 | $82.41 | 14,497 | $1.2M | 38.7% |
| 3 | $82.41 | 14,497 | $1.2M | 38.7% |
| 4 | $83.38 | 2,978 | $248K | 8.0% |
| 5 | $83.38 | 2,978 | $248K | 8.0% |
| 6 | $84.64 | 1,800 |
| $152K |
| 4.9% |
| 7 | $85.28 | 600 | $51K | 1.7% |
| Total | $65.95 avg | 46,850 | $3.1M | 100% |
| Filing → |
| EW | SELL | 2024-03-04 | $3.7M | — | Filing → |
| EW | SELL | 2024-02-05 | $5.0M | — | Filing → |
| EW | SELL | 2024-01-05 | $2.3M | — | Filing → |